Eli Lilly and Company (LLY) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Eli Lilly and Company presented at the Bernstein 42nd Annual Strategic Decisions Conference on May 28, 2026. The discussion featured Daniel Skovronsky, the Chief Scientific Officer, who shared insights on the company's research and development approach. The conference aimed to provide a deeper understanding of Eli Lilly's strategies and future directions in the pharmaceutical industry.
- ▪Daniel Skovronsky is the Chief Scientific Officer and President of Lilly Research Laboratories.
- ▪The conference took place on May 28, 2026, at 1:30 PM EDT.
- ▪The discussion focused on Eli Lilly's evolving approach to research and development.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4909804-eli-lilly-and-company-lly-presents-at-bernstein-42nd-annual-strategic-decisions-conference"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
